Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Reason Magazine (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

The Federal Trade Commission Won't Give Up Its Crusade Against Meta

% of readers think this story is Fact. Add your two cents.


Illustration featuring a smartphone with social media apps displayed beside an FTC logo | Illustration: Inkdropcreative1/Bigtunaonline/Dreamstime/Wikimedia Commons

The Federal Trade Commission (FTC) announced on Tuesday that it will appeal the ruling in its monopoly case against Meta. Legal and economic antitrust experts see no way the FTC can win on appeal, given the factual findings of the federal court in November.

While the actual appeal has not yet been filed, the FTC Bureau of Competition Director Daniel Guarnera said that “the Trump-Vance FTC will continue fighting its historic case against Meta to ensure that competition can thrive across the country to the benefit of all Americans and U.S. businesses.” The decision to appeal, coupled with Guarnera’s statement, is yet more evidence that President Donald Trump’s FTC has embraced the big-is-bad mantra of its Democratic predecessor

The FTC brought its lawsuit against Meta under Trump’s first administration in December 2020, alleging that the company violated the Sherman Antitrust Act’s prohibition on monopolies by purchasing Instagram and WhatsApp. Nearly five years later, Judge James Boasberg of the U.S. District Court for the District of Columbia ruled in no uncertain terms that Meta doesn’t have anything approaching a monopoly in the social media market. 

The FTC argued that Meta maintained a monopoly in the personal social networking market, which it defined as including Facebook, Instagram, Snapchat, and MeWe (a privacy-focused social network). In such a narrow market, Meta’s market share would be 85 percent of time spent, per the FTC’s April 2025 opening statement slides. Boasberg rejected the FTC’s definition in favor of Meta’s social media market, which includes YouTube and TikTok, based on overwhelming economic evidence showing users substitute these apps for Instagram and Facebook. In this market, Boasberg found Meta’s “share…comes out to around 30% of time spent.”

Boasberg cites much case law to establish that 30 percent is a “modest share [that] cannot establish monopoly power.” Examples include the U.S. Court of Appeals for the 7th Circuit’s ruling in Blue Cross & Blue Shield United of Wis. v. Marshfield Clinic, which found “fifty percent is below any accepted benchmark for inferring monopoly power from market share,” and the 2nd Circuit’s ruling in United States v. Aluminum Co. of America, which concluded that “it is doubtful whether sixty or sixty-four percent would be enough [to establish monopoly]; and certainly thirty-three per cent is not.” Meta’s 30 percent share is substantially below the former, and less than the latter. 

Given Meta’s mere plurality of the social media market, the FTC’s path to victory is opaque at best, and likely impossible.

Brian Albrecht, chief economist at the International Center for Law and Economics, tells Reason that the FTC faces “an uphill battle.” Albrecht says it’s unlikely that the FTC will challenge Boasberg’s findings of fact, but “whether [he] applied the correct framework for market definition, whether he demanded a form of proof that antitrust law doesn’t require, or whether he excluded or discounted evidence for legally improper reasons.” The success of this strategy is doubtful because Boasberg, “by most accounts, engaged seriously with the standard antitrust tools [and]…found the FTC’s market definition unconvincing after weighing the evidence, not on a technicality,” explains Albrecht. 

Albrecht is joined in his evaluation of the FTC’s likelihood of appellate success by Joe Coniglio, director of antitrust and innovation at the Information Technology and Innovation Foundation. Conligio says “there is virtually no chance that [Boasberg's] robust factual findings will be found clearly erroneous on appeal” and tells Reason that “the FTC’s only conceivable hope is to prove that Judge Boasberg got the law wrong in holding that the FTC ‘had to show that Meta is violating the law now.’” But Coniglio says Boasberg got the law right and describes the FTC’s decision to appeal as “a very poor use of the FTC’s prosecutorial discretion to spend thousands, if not millions, more of American taxpayers’ money on a case that was always a loser.”

Losing at the district level was insufficiently embarrassing for the federal antitrust regulator, whose decision to appeal evidences a combination of stubbornness and masochism. 

The post The Federal Trade Commission Won’t Give Up Its Crusade Against Meta appeared first on Reason.com.


Source: https://reason.com/2026/01/21/the-federal-trade-commission-wont-give-up-its-crusade-against-meta/


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login